These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 29806603)
41. Genetic and epigenetic alterations affecting PARK-2 expression in cervical neoplasm among North Indian patients. Naseem A; Bhat ZI; Kalaiarasan P; Kumar B; Gandhi G; Rizvi MMA Tumour Biol; 2017 Jun; 39(6):1010428317703635. PubMed ID: 28631565 [TBL] [Abstract][Full Text] [Related]
42. Correlation between methylation of the p16 promoter and cervical cancer incidence. Wang FL; Yang Y; Liu ZY; Qin Y; Jin T Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2351-2356. PubMed ID: 28617556 [TBL] [Abstract][Full Text] [Related]
43. Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression. Song Y; Zhang C Cancer Chemother Pharmacol; 2009 Mar; 63(4):605-13. PubMed ID: 18521605 [TBL] [Abstract][Full Text] [Related]
45. Promoter methylation and expression of DNA repair genes MGMT and ERCC1 in tissue and blood of rectal cancer patients. Shalaby SM; El-Shal AS; Abdelaziz LA; Abd-Elbary E; Khairy MM Gene; 2018 Feb; 644():66-73. PubMed ID: 29080834 [TBL] [Abstract][Full Text] [Related]
46. Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer. Ivanova T; Petrenko A; Gritsko T; Vinokourova S; Eshilev E; Kobzeva V; Kisseljov F; Kisseljova N BMC Cancer; 2002 Mar; 2():4. PubMed ID: 11945179 [TBL] [Abstract][Full Text] [Related]
47. Changes in gene expression induced by chemoradiation in advanced cervical carcinoma: a microarray study of RTOG C-0128. Zempolich K; Fuhrman C; Milash B; Flinner R; Greven K; Ryu J; Forbes A; Kerlin K; Nichols RC; Gaffney DK Gynecol Oncol; 2008 May; 109(2):275-9. PubMed ID: 18299147 [TBL] [Abstract][Full Text] [Related]
48. Aberrant Methylation of the SOX21-AS1 Promoter Region Promotes Gene Expression and Its Clinical Value in Cervical Cancer. Du P; Zhi Y; Wang R; Li Y; Li H; Zhang X; Cheng G; Li X Reprod Sci; 2021 Feb; 28(2):532-540. PubMed ID: 33095426 [TBL] [Abstract][Full Text] [Related]
49. Reactivation of the tumour suppressor RASSF1A in breast cancer by simultaneous targeting of DNA and E2F1 methylation. Montenegro MF; Sáez-Ayala M; Piñero-Madrona A; Cabezas-Herrera J; Rodríguez-López JN PLoS One; 2012; 7(12):e52231. PubMed ID: 23251702 [TBL] [Abstract][Full Text] [Related]
50. Association between RASSF1A Promoter Hypermethylation and Oncogenic HPV Infection Status in Invasive Cervical Cancer: a Meta-analysis. Li JY; Huang T; Zhang C; Jiang DJ; Hong QX; Ji HH; Ye M; Duan SW Asian Pac J Cancer Prev; 2015; 16(14):5749-54. PubMed ID: 26320446 [TBL] [Abstract][Full Text] [Related]
52. Promoter hypermethylation of RASSF1A, MGMT, and HIC-1 genes in benign and malignant colorectal tumors. Abouzeid HE; Kassem AM; Abdel Wahab AH; El-mezayen HA; Sharad H; Abdel Rahman S Tumour Biol; 2011 Oct; 32(5):845-52. PubMed ID: 21274674 [TBL] [Abstract][Full Text] [Related]
53. Overexpression of Ribosomal RNA in the Development of Human Cervical Cancer Is Associated with rDNA Promoter Hypomethylation. Zhou H; Wang Y; Lv Q; Zhang J; Wang Q; Gao F; Hou H; Zhang H; Zhang W; Li L PLoS One; 2016; 11(10):e0163340. PubMed ID: 27695092 [TBL] [Abstract][Full Text] [Related]
54. Association between Gene Promoter Methylation and Cervical Cancer Development: Global Distribution and A Meta-analysis. El Aliani A; El-Abid H; El Mallali Y; Attaleb M; Ennaji MM; El Mzibri M Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):450-459. PubMed ID: 33441308 [TBL] [Abstract][Full Text] [Related]
55. Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients. Chan MW; Chan LW; Tang NL; Lo KW; Tong JH; Chan AW; Cheung HY; Wong WS; Chan PS; Lai FM; To KF Int J Cancer; 2003 May; 104(5):611-6. PubMed ID: 12594816 [TBL] [Abstract][Full Text] [Related]
56. Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes. Banno K; Yanokura M; Kawaguchi M; Kuwabara Y; Akiyoshi J; Kobayashi Y; Iwata T; Hirasawa A; Fujii T; Susumu N; Tsukazaki K; Aoki D Int J Oncol; 2007 Oct; 31(4):713-20. PubMed ID: 17786301 [TBL] [Abstract][Full Text] [Related]
57. Epigenetic modulation of BRCA-1 and MGMT genes, and histones H4 and H3 are associated with breast tumors. Paydar P; Asadikaram G; Nejad HZ; Akbari H; Abolhassani M; Moazed V; Nematollahi MH; Ebrahimi G; Fallah H J Cell Biochem; 2019 Aug; 120(8):13726-13736. PubMed ID: 30938887 [TBL] [Abstract][Full Text] [Related]
58. Association Between Type-specific HPV Infections and hTERT DNA Methylation in Patients with Invasive Cervical Cancer. Molano M; Moreno-Acosta P; Morales N; Burgos M; Buitrago L; Gamboa O; Alvarez R; Garland SM; Tabrizi SN; Steenbergen RD; Mejía JC Cancer Genomics Proteomics; 2016 11-12; 13(6):483-491. PubMed ID: 27807071 [TBL] [Abstract][Full Text] [Related]
59. Predictive value of CHFR and MLH1 methylation in human gastric cancer. Li Y; Yang Y; Lu Y; Herman JG; Brock MV; Zhao P; Guo M Gastric Cancer; 2015 Apr; 18(2):280-7. PubMed ID: 24748501 [TBL] [Abstract][Full Text] [Related]
60. Aberrant promoter methylation and silencing of RASSF2A gene in cervical cancer. Zhang X; Ma Y; Wu Y; Lin L; Ma X; Zhang Y J Obstet Gynaecol Res; 2014 May; 40(5):1375-81. PubMed ID: 24605823 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]